Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


21 febrero 2013

SynCardia Total Artificial Heart Patient with End-Stage Renal Failure Recovers Kidney Function after Two Months of Support

Healthcare Sales & Marketing Network

20-Year-Old Tiernee Gonzalez Begins Producing Urine Day Before Scheduled Surgery to Implant Permanent Catheter. At only 20 years old, Tiernee Gonzalez has been battling two major diseases for most of her young life: heart failure and kidney failure. When she became the first patient at Cincinnati Children s Hospital Medical Center to receive the SynCardia temporary Total Artificial Heart on Nov. 9, her doctors hoped it would bring her one step closer to winning her battle against end-stage heart failure. What they didn t expect, was that it would also help save her one remaining kidney

16 enero 2013

Argon Medical Devices, Inc. Announces the Launch of the Cleaner15 Rotational Thrombectomy System

PRNewswire

Furthering its commitment to advancing the treatment of patients diagnosed with ESRD (End Stage Renal Disease), Argon Medical Devices, Inc. takes another leap forward with the launch of the Cleaner15 Rotational Thrombectomy System. The addition of Cleaner15 to Argon Medical s product portfolio provides physicians with another weapon in their arsenal to safely and effectively restore patency in occluded arteriovenous fistulae and synthetic grafts.

28 enero 2013

Interventional treatment with radioactive beads could help colon cancer patients live longer

Interventional News

Patients who received minimally invasive treatment with yttrium-90 (Y-90) radioactive beads to treat colorectal cancer that had spread to the liver lived almost a year longer compared to those who received the standard of care therapy, data presented at the 5th annual Symposium on Clinical Interventional Oncology, in collaboration with the International Symposium on Endovascular Therapy (ISET) has suggested.

06 febrero 2013

Rethinking patients outlook on vein health

Phys Biz Tech

The Society of Interventional Radiology (SRI) — an international group comprised of physicians, scientists and other allied health professionals — joined the Rethink Varicose Veins alliance to aid in the broadening of public awareness regarding the risks of varicose veins and chronic venous insufficiency.

13 febrero 2013

Prostate Cancer Patients Treated with Proton Therapy at Loma Linda University Medical Center Show Excellent Quality of Life

Healthcare Sales & Marketing Network

New Breakthrough Report Reaffirms Proton Therapy Efficacy; Post-Treatment Quality of Life on Par with Men Never Afflicted by Cancer. A staggering 99 percent of prostate cancer patients treated with proton therapy believe they made the best treatment decisions for themselves, according to a new report released today at the National Proton Conference in Washington, D.C. The report analyzed outcomes and satisfaction of approximately 6,400 prostate cancer patients, more than 80 percent of whom received treatment at Loma Linda University Medical Center’s (LLUMC) James M. Slater Proton Treatment and Research Center

08 febrero 2013

Pregnancy following uterine artery embolization is a viable option for women under 40 years old

Interventional News

A study by Bruce McLucas, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California, USA, and published ahead-of-print in Minimally Invasive Therapy has said that women who desire future fertility could be considered for uterine artery embolization. He reported the outcomes of his patient cohort who became pregnant after the procedure.

25 enero 2013

ReCor Medical receives the CE mark for its second generation ultrasound-based Paradise Renal Denervation System

Interventional News

ReCor Medical has received the CE mark for its next-generation Paradise system, a minimally invasive 6Fr over-the-wire (OTW) ultrasound device for treating resistant high bloodpressure. Additionally, the treatment parameters of this new device have been further enhanced to reduce energy delivery to 30 seconds by maximising cooling of the endothelium and efficiently treating the nerves circumferentially.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.